A detailed history of Altus Wealth Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Altus Wealth Group LLC holds 1,851 shares of AMGN stock, worth $551,190. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,851
Previous 1,847 0.22%
Holding current value
$551,190
Previous $577,000 3.29%
% of portfolio
0.26%
Previous 0.29%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$309.38 - $337.38 $1,237 - $1,349
4 Added 0.22%
1,851 $596,000
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $386,242 - $469,385
-1,470 Reduced 44.32%
1,847 $577,000
Q1 2024

May 02, 2024

BUY
$268.87 - $324.56 $30,382 - $36,675
113 Added 3.53%
3,317 $943,000
Q4 2023

Jan 29, 2024

BUY
$255.7 - $288.46 $78,755 - $88,845
308 Added 10.64%
3,204 $922,000
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $6,559 - $8,143
-30 Reduced 1.03%
2,896 $778,000
Q2 2023

Aug 03, 2023

BUY
$214.27 - $253.37 $5,142 - $6,080
24 Added 0.83%
2,926 $649,000
Q1 2023

May 01, 2023

SELL
$225.79 - $275.2 $27,320 - $33,299
-121 Reduced 4.0%
2,902 $701,000
Q4 2022

Jan 18, 2023

BUY
$229.03 - $291.01 $128,256 - $162,965
560 Added 22.74%
3,023 $0
Q2 2022

Aug 10, 2022

SELL
$230.71 - $256.74 $27,915 - $31,065
-121 Reduced 4.68%
2,463 $524,000
Q1 2022

May 09, 2022

SELL
$219.27 - $242.57 $2,850 - $3,153
-13 Reduced 0.5%
2,584 $625,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $26,649 - $30,498
134 Added 5.44%
2,597 $584,000
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $55,190 - $64,662
260 Added 11.8%
2,463 $524,000
Q2 2021

Aug 12, 2021

SELL
$233.58 - $259.14 $20,788 - $23,063
-89 Reduced 3.88%
2,203 $537,000
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $38,390 - $44,737
173 Added 8.16%
2,292 $567,000
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $458,509 - $546,002
2,119 New
2,119 $488,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $159B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Altus Wealth Group LLC Portfolio

Follow Altus Wealth Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altus Wealth Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altus Wealth Group LLC with notifications on news.